Management of Gastroesophageal Reflux Disease (GERD)

Initial Approach and Lifestyle Modifications

The American Gastroenterological Association recommends a 4-8 week trial of single-dose PPI therapy for patients with typical GERD symptoms without alarm symptoms, without the need for initial endoscopy 2, 1
For patients with persistent symptoms, increasing to twice-daily PPI dosing or switching to a more potent acid suppressive agent is recommended 2
The American College of Gastroenterology suggests that after symptom control is achieved, PPI should be tapered to the lowest effective dose 2, 1
Weight loss is recommended for all overweight or obese patients with GERD, as it can help alleviate symptoms 3, 1
Elevation of the head of the bed (6-8 inches) is recommended for patients with nighttime symptoms or regurgitation when recumbent 3, 1
Avoiding lying down for 2-3 hours after meals can help reduce symptoms 1
Specific dietary modifications should be individualized based on symptom triggers (e.g., avoiding alcohol, coffee, spicy foods if they consistently trigger symptoms) 3

PPIs (omeprazole, lansoprazole, etc.) are the cornerstone of GERD management due to superior efficacy in healing esophagitis and symptom relief 3
Standard PPI dosing should be taken 30-60 minutes before meals for optimal effect 1
For typical GERD symptoms, a 4-8 week course of PPI therapy is recommended initially 2
H2RAs (ranitidine, famotidine) can be used as add-on therapy to PPI, particularly for nighttime symptoms 4
Antacids and alginates can provide rapid, short-term relief of breakthrough symptoms 4
Adding sodium alginate to PPI can improve symptom resolution in patients with non-erosive reflux disease (NERD) 4

If symptoms persist despite optimized PPI therapy, endoscopy should be performed to assess for erosive disease or alternative diagnoses 2
In the absence of erosive disease on endoscopy, prolonged wireless pH monitoring off PPI therapy should be considered to confirm GERD diagnosis 2
Optimizing PPI therapy (timing, compliance, dosing) is recommended for patients with refractory GERD 4, 2
Adding bedtime H2RA (though tachyphylaxis may develop with continued use) can be considered for patients with refractory GERD 4, 2
Consider baclofen as add-on therapy to PPI in selected cases, though limited by side effects including somnolence and dizziness 4
For confirmed PPI-refractory GERD, surgical options like laparoscopic fundoplication may be considered in experienced centers 4

For infants with GERD, lifestyle modifications including feeding changes (smaller, more frequent feedings) and positioning therapy (keeping infant upright after feeds) are recommended 5, 6
For formula-fed infants with GERD, consider thickened feedings or trial of extensively hydrolyzed protein formula if milk protein allergy is suspected 6
Acid suppressants (H2RAs, PPIs) should be used judiciously in pediatric patients 5, 6
Surgery is recommended only in patients with objectively documented gastroesophageal reflux 4

For patients on long-term PPI therapy, periodically reassess the need for continued therapy and attempt to use the lowest effective dose 2, 1
If long-term PPI therapy is planned, objective reflux testing should be offered to confirm the GERD diagnosis 2
For functional heartburn (normal acid exposure, negative symptom association), consider neuromodulators (tricyclic antidepressants, selective serotonin reuptake inhibitors) 7
PPI therapy is generally safe for long-term use, though patients should be informed about potential risks and benefits 2, 1